MoonLake Immunotherapeutics (MLTX)
NASDAQ:MLTX
MLTX Analyst Ratings
Moderate Buy
11 Buy
2 Hold
2 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
MLTX Stock 12 Month Forecast
Average Price Target
$28.57
▲(64.57% Upside)
| Highest Price Target$70.00 | Average Price Target$28.57 | Lowest Price Target$6.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
LifeSci Capital
$16→$33
Buy
90.09%
Upside
Reiterated
03/31/26
H.C. Wainwright
$40
Buy
130.41%
Upside
Reiterated
03/30/26
TD Cowen
―
Buy
―
Reiterated
03/30/26
Wedbush
$34
Buy
95.85%
Upside
Reiterated
03/30/26
Wolfe Research
$12→$24
Buy
38.25%
Upside
Upgraded
03/23/26
Citi
$6
Sell
-65.44%
Downside
Reiterated
03/20/26
Rothschild & Co Redburn
$12→$40
Buy
130.41%
Upside
Upgraded
03/19/26
Clear Street
$45→$70
Buy
303.23%
Upside
Assigned
03/11/26
BTIG
$24→$30
Buy
72.81%
Upside
Reiterated
03/02/26
Stifel Nicolaus
$13→$19
Hold
9.45%
Upside
Reiterated
03/01/26
RBC Capital
$12→$13
Hold
-25.12%
Downside
Reiterated
02/27/26
Goldman Sachs
$10→$11
Sell
-36.64%
Downside
Reiterated
02/26/26
Needham
$25
Buy
44.01%
Upside
Reiterated
02/25/26
Guggenheim
$20
Buy
15.21%
Upside
Reiterated
02/24/26
Oppenheimer
$30→$35
Buy
101.61%
Upside
Reiterated
02/24/26
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
LifeSci Capital
$16→$33
Buy
90.09%
Upside
Reiterated
03/31/26
H.C. Wainwright
$40
Buy
130.41%
Upside
Reiterated
03/30/26
TD Cowen
―
Buy
―
Reiterated
03/30/26
Wedbush
$34
Buy
95.85%
Upside
Reiterated
03/30/26
Wolfe Research
$12→$24
Buy
38.25%
Upside
Upgraded
03/23/26
Citi
$6
Sell
-65.44%
Downside
Reiterated
03/20/26
Rothschild & Co Redburn
$12→$40
Buy
130.41%
Upside
Upgraded
03/19/26
Clear Street
$45→$70
Buy
303.23%
Upside
Assigned
03/11/26
BTIG
$24→$30
Buy
72.81%
Upside
Reiterated
03/02/26
Stifel Nicolaus
$13→$19
Hold
9.45%
Upside
Reiterated
03/01/26
RBC Capital
$12→$13
Hold
-25.12%
Downside
Reiterated
02/27/26
Goldman Sachs
$10→$11
Sell
-36.64%
Downside
Reiterated
02/26/26
Needham
$25
Buy
44.01%
Upside
Reiterated
02/25/26
Guggenheim
$20
Buy
15.21%
Upside
Reiterated
02/24/26
Oppenheimer
$30→$35
Buy
101.61%
Upside
Reiterated
02/24/26
Best Analysts Covering MoonLake Immunotherapeutics
3 Months
xxx
Success Rate
17/26 ratings generated profit
Average Return
+29.54%
reiterated a xxx
rating 6 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 65.38% of your transactions generating a profit, with an average return of +29.54% per trade.
1 Year
Success Rate
13/26 ratings generated profit
Average Return
+65.01%
reiterated a buy rating 6 months ago
Copying Thomas Smith's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +65.01% per trade.
2 Years
xxx
Success Rate
9/26 ratings generated profit
Average Return
+43.06%
reiterated a xxx
rating 6 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 34.62% of your transactions generating a profit, with an average return of +43.06% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
MLTX Analyst Recommendation Trends
Rating
Dec 25
Jan 26
Feb 26
Mar 26
Apr 26
Strong Buy
9
11
10
19
14
Buy
3
6
9
10
7
Hold
4
28
44
43
24
Sell
1
1
2
2
1
Strong Sell
0
0
1
2
2
total
17
46
66
76
48
Each month's total comprises the sum of three months' worth of ratings.
MLTX Financial Forecast
MLTX Stock Forecast FAQ
What is MLTX’s average 12-month price target, according to analysts?
Based on analyst ratings, MoonLake Immunotherapeutics’s 12-month average price target is 28.57.
What is MLTX’s upside potential, based on the analysts’ average price target?
MoonLake Immunotherapeutics has 64.57% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is MLTX a Buy, Sell or Hold?
MoonLake Immunotherapeutics has a consensus rating of Moderate Buy which is based on 11 buy ratings, 2 hold ratings and 2 sell ratings.
What is MoonLake Immunotherapeutics’s price target?
The average price target for MoonLake Immunotherapeutics is 28.57. This is based on 15 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $70.00 ,the lowest forecast is $6.00. The average price target represents 64.57% Increase from the current price of $17.36.
The highest analyst price target is $70.00 ,the lowest forecast is $6.00. The average price target represents 64.57% Increase from the current price of $17.36.
What do analysts say about MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 15 Wall Streets Analysts.
How can I buy shares of MLTX?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.